73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Research shows that DOPA protects against melanoma

Research shows that DOPA protects against melanoma

byPerelman School of Medicine at the University of PennsylvaniaHistologic characterization of representative orthotopic skin and resulting tumors, including MC and proliferation markers MITF (re

Research shows that DOPA protects against melanoma

byPerelman School of Medicine at the University of PennsylvaniaHistologic characterization of representative orthotopic skin and resulting tumors, including MC and proliferation markers MITF (re
Study finds triple-negative breast cancer tumors with increased immune cells have lower risk of recurrence after surgery

Study finds triple-negative breast cancer tumors with increased immune cells have lower risk of recurrence after surgery

by Mayo ClinicCredit: Unsplash/CC0 Public DomainA new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cel

Study finds triple-negative breast cancer tumors with increased immune cells have lower risk of recurrence after surgery

by Mayo ClinicCredit: Unsplash/CC0 Public DomainA new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cel
Genomic testing can identify African American prostate cancer patients who have high-risk disease

Genomic testing can identify African American prostate cancer patients who have high-risk disease

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainAfrican American men tend to be diagnosed more frequently with prostate cancer and have higher mortality

Genomic testing can identify African American prostate cancer patients who have high-risk disease

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainAfrican American men tend to be diagnosed more frequently with prostate cancer and have higher mortality
New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

byCanadian Medical Association JournalCredit: Unsplash/CC0 Public DomainCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and

New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

byCanadian Medical Association JournalCredit: Unsplash/CC0 Public DomainCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and
AI with infrared imaging enables precise colon cancer diagnostics

AI with infrared imaging enables precise colon cancer diagnostics

byRuhr-Universitaet-BochumGraphical abstract. Credit:European Journal of Cancer(2023). DOI: 10.1016/j.ejca.2022.12.026The immense progress in the field of therapy options over the pa

AI with infrared imaging enables precise colon cancer diagnostics

byRuhr-Universitaet-BochumGraphical abstract. Credit:European Journal of Cancer(2023). DOI: 10.1016/j.ejca.2022.12.026The immense progress in the field of therapy options over the pa
Researchers uncover on/off switch for breast cancer metastasis

Researchers uncover on/off switch for breast cancer metastasis

by Rebecca McClellan,Stanford UniversitySongnan Wang (left) and Lingyin Li (right) found that a protein called ENPP1 acts as an on/off switch for breast cancer metastases. High protein levels le

Researchers uncover on/off switch for breast cancer metastasis

by Rebecca McClellan,Stanford UniversitySongnan Wang (left) and Lingyin Li (right) found that a protein called ENPP1 acts as an on/off switch for breast cancer metastases. High protein levels le
Pembrolizumab shows survival benefit for patients with renal cancer

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,
Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval
Method that rapidly predicts breast cancer survival rates clinically validated

Method that rapidly predicts breast cancer survival rates clinically validated

by Ian Mundell,Imperial College LondonFlow diagram of the Digistain protocol. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s10549-023-07229-yDigistain, a company w

Method that rapidly predicts breast cancer survival rates clinically validated

by Ian Mundell,Imperial College LondonFlow diagram of the Digistain protocol. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s10549-023-07229-yDigistain, a company w
How colliding genetic processes drive aggressive cancers

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch
Study proposes streamlined approach to developing cancer drugs

Study proposes streamlined approach to developing cancer drugs

by Tom Dinki,University at BuffaloBlessing Ogboo works in the Natural Sciences Complex chemistry lab of David Heppner. Credit: Douglas Levere / Univeristy at BuffaloDrug discovery can be a frust

Study proposes streamlined approach to developing cancer drugs

by Tom Dinki,University at BuffaloBlessing Ogboo works in the Natural Sciences Complex chemistry lab of David Heppner. Credit: Douglas Levere / Univeristy at BuffaloDrug discovery can be a frust